Cytokinetics, Incorporated (CYTK) announced positive data from the Phase 1 study of its drug candidate CK-586, a cardiac myosin inhibitor being developed for heart failure with preserved ejection fraction (HFpEF). The study demonstrated safety, tolerability, and favorable pharmacokinetic properties, paving the way for potential once-daily fixed-dose administration in future clinical trials.
Windtree Therapeutics, Inc. (WINT) is seeing its stock rise after completing enrollment in its SEISMiC Extension Phase 2b study of istaroxime for early cardiogenic shock. This study builds upon positive results from a previous trial, focusing on longer dosing duration and exploring potential benefits of a tapering dosage regimen.
This story recounts the emotional rollercoaster a father experiences while battling for his son’s life, navigating heart failure, multiple hospitalizations, and the agonizing wait for a heart transplant. It highlights the strength and resilience of families facing life-altering challenges, offering hope and raising awareness about the critical role of organizations like Great Ormond Street Hospital.
A new study published in The Lancet suggests that semaglutide, a drug commonly used for diabetes and weight loss, may significantly reduce the risk of cardiovascular death and worsening heart failure in patients with specific types of heart failure. The analysis, combining data from four clinical trials, found a 31% reduction in combined cardiovascular death or worsening heart failure events in those taking semaglutide.
In a groundbreaking medical advancement, a 54-year-old grandmother named Lisa Pisano has successfully received the first-ever combined transplant of a gene-edited pig kidney and a mechanical heart pump. The innovative procedure, performed by surgeons at NYU Langone Health, offers hope to individuals facing end-stage organ failure and a shortage of human organ donations. Pisano, who suffers from both end-stage kidney disease and heart failure, was not a candidate for a traditional heart and kidney transplant due to her complex medical conditions. However, the combined pig kidney and heart pump transplant has provided her with a new lease on life.
Doctors at NYU Langone Health have performed a groundbreaking surgery, transplanting a pig kidney into a patient who was near death. The patient, Lisa Pisano, also received a mechanical heart pump to stabilize her failing heart. Pisano is the second patient ever to receive a pig kidney, following a similar transplant at Massachusetts General Hospital last month. This latest surgery marks a significant step forward in the effort to make animal-to-human transplantation a reality.
A New Jersey woman near death has undergone a groundbreaking surgery that involved transplanting a pig kidney into her body. The operation, part of a novel treatment approach, was combined with a heart pump implantation to stabilize her failing heart. This marks the second such pig kidney transplant to be performed, following a similar surgery last month at Massachusetts General Hospital. The patient, Lisa Pisano, is recovering well and has taken her first steps with the assistance of a walker. The success of this surgery raises hopes for addressing the shortage of donated organs and offers potential solutions for patients with severe organ failure.
A groundbreaking surgery has given hope to patients with failing hearts and kidneys. Doctors at NYU Langone Health have successfully transplanted a pig kidney into a woman who was near death. This is only the second successful pig-to-human kidney transplant ever performed. The patient, Lisa Pisano, is recovering well and has taken her first steps with the help of a walker. The transplant was part of a combination of surgeries that also stabilized Pisano’s failing heart with a mechanical pump. This novel approach could potentially save the lives of thousands of people who are waiting for organ transplants.
Amendola Communications, an award-winning healthcare technology and life sciences public relations and marketing firm, has been selected by Peerbridge Health, a developer of a hospital-grade, remote diagnostic and monitoring platform that harnesses artificial intelligence (AI) for early detection of heart failure and other conditions, to implement a national PR program.
Peerbridge Health’s Peerbridge Cor™ is an AI-enabled, 3-lead, 2-channel wireless ambulatory ECG device that has shown a nearly 96% accuracy rate in identifying heart failure in patients utilizing ECG as the only input. Amendola will work with Peerbridge Health to educate the industry on the life-saving potential of early detection of heart failure through AI-enabled remote monitoring technology.
Academy Award-winning actor Louis Gossett Jr. passed away at 87 from chronic obstructive pulmonary disease (COPD), heart failure, and atrial fibrillation. His death certificate revealed the contributing factors, as reported by People magazine. Gossett’s cousin spoke of his legacy as a man who fought racism with dignity and humor, cherishing human connection over material possessions.
